Cracking the code of healthy aging: new approaches to staying healthy as we age

The Impact of Climate Change

Climate Change: Severe Droughts Require Action to Avoid a Food Crisis

Heart and Kidneys

Five Reasons to Care About the Risks of Chronic Kidney Disease

Innovation in Cell and Gene Therapy

Charting a New Course for Parkinson’s Disease

Merchants of Doubt

How Scientific Consensus is Being Systematically Undermined

Latest News

July 29, 2021

Bayer Provides Update on Path to Closure of Roundup™ Litigation

July 21, 2021

Not intended for U.S. and UK Media

Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU

July 09, 2021

Not intended for U.S. and UK Media

U.S. FDA approves finerenone for the treatment of patients with chronic kidney disease associated with type 2 diabetes

Our Stories

Lung cancer diagnosis and treatment

How screening, artificial intelligence and genomic testing can help to fight a severe disease

When normal is not normal – let’s talk about Women’s Health

Support and solidarity after devastating floods

#TeamBayer joins forces: “We can make it together”

Heart and Kidneys

Five Reasons to Care About the Risks of Chronic Kidney Disease

People & Perspective

Merchants of Doubt

Impactful Innovations

Putting Food Security on a Plate

Cracking the code of healthy aging: new approaches to staying healthy as we age

Bayer Vitamins and Supplements

Supporting Nutrition

Myths about Nutrition and Pregnancy